1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Sleep and sleep conditions

Solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoea

Technology appraisal guidance [TA777] Published: 09 March 2022

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Tools and resources

Tools to help you put the guidance into practice.

Guidance into practice

  • About the Into practice guide  
  • Practical steps to improving the quality of care and services using NICE guidance